Group 1 - The latest LPR values for 1-year and 5-year loans will be announced on August 20, with the current rates at 3.0% and 3.5% respectively, unchanged from June [2] - A total of 711.8 billion yuan in reverse repos will mature next week, with specific maturities scheduled from Monday to Friday [3] - The Hang Seng Index Company will announce the results of the second quarter index review on August 22, with changes effective from September 8, 2025 [4] Group 2 - The Jackson Hole Global Central Bank Conference will take place from August 21 to 23, featuring a speech by Federal Reserve Chairman Jerome Powell on August 22 [5] - The Federal Reserve will release the minutes of its monetary policy meeting on August 21, amid a pause in interest rate cuts since early this year, with current rates between 4.25% and 4.5% [6] - Nearly 100 billion yuan in market value of restricted stocks will be unlocked next week, with 35 stocks facing unlocks, including 29.54 billion yuan from United Imaging Healthcare [7][8] Group 3 - One new stock, Balanshi, is set to be issued next week on August 19, with approximately 19 million shares expected to raise nearly 300 million yuan [11]

Core Viewpoint - The company, Shanghai United Imaging Healthcare Co., Ltd., is set to release 230,859,012 restricted shares for trading on August 22, 2025, following a 36-month lock-up period since its initial public offering (IPO) [1][2][8]. Group 1: Listing Details - The type of shares being listed is restricted shares from the company's IPO, with a total of 230,859,012 shares to be released [1][2]. - The total number of shares after the IPO is 824,157,988, with restricted shares amounting to 776,907,446 and unrestricted shares at 47,250,542 [1]. - The lock-up period for the restricted shares is 36 months from the IPO date, which began on August 22, 2022 [2][8]. Group 2: Shareholder Commitments - The actual controller of the company, Xue Min, has committed not to transfer or manage the shares held prior to the IPO for 36 months and has additional conditions for extending the lock-up period if certain price conditions are met [2][3]. - The controlling shareholder, United Imaging Group, and its associated entities have made similar commitments regarding the non-transfer of shares for 36 months and adherence to legal regulations during any future share reductions [4][5]. Group 3: Compliance and Verification - There are no reported instances of fund occupation by the controlling shareholders or related parties [6]. - The intermediary institutions have verified that the shareholders have complied with their commitments regarding the restricted shares, confirming that the listing of these shares meets legal and regulatory requirements [7].

Group 1 - The core point of the news is that Sichuang Medical (300078) has received a notice from the Hangzhou Public Security Bureau regarding an investigation into alleged fraudulent issuance of securities, and the company will cooperate with the investigation [1] - As of August 15, 2025, the investigation is still in the police investigation stage, and no clear conclusion has been reached [1] - The company has committed to timely information disclosure based on the progress of the case [1] Group 2 - Sichuang Medical's stock price has increased by 30.59% year-to-date, and the number of shareholders has grown by 51.39% compared to the end of 2024, reaching 73,800 [3] - Next week, 25 stocks will face a total unlock market value of 795.29 billion, with significant unlocks from companies like United Imaging Healthcare and GeKong Microelectronics [5][6] - Among the stocks facing unlock, some have seen institutional research, including New Coordinates and Leshan Electric Power, which recently reported on their technological advancements and operational updates [10]

Core Viewpoint - The announcement details the upcoming listing and circulation of restricted shares for Shanghai United Imaging Healthcare Co., Ltd., which will take place on August 22, 2025, involving a total of 230,859,012 shares [2][4][10]. Group 1: Listing Details - The type of stock being listed is restricted shares from the initial public offering (IPO) [2]. - The total number of shares to be listed is 230,859,012 [3]. - The shares represent 28.01% of the company's total share capital, which amounts to 824,157,988 shares post-IPO [4]. Group 2: Lock-up Period and Commitments - The lock-up period for these restricted shares is 36 months from the date of the company's IPO, which began on August 22, 2022 [4]. - The actual controller of the company, Xue Min, has made commitments regarding the lock-up of shares, including not transferring or managing the shares during the lock-up period [6]. - If the stock price falls below the IPO price for 20 consecutive trading days within the first six months post-IPO, the lock-up period will automatically extend by six months [6]. Group 3: Compliance and Verification - The company has confirmed that there have been no changes in share capital due to profit distribution or other factors since the formation of the restricted shares [5]. - The company and its major shareholders have adhered to their commitments regarding the lock-up of shares, and there are no instances of fund occupation by controlling shareholders [9][10]. - The underwriting institutions have verified that the listing of restricted shares complies with relevant laws and regulations [10].

Core Viewpoint - The China Securities Index for Healthcare Equipment and Services has shown significant growth, indicating a positive trend in the healthcare sector [1]. Group 1: Index Performance - The CSI Healthcare Equipment and Services Index increased by 1.49%, reaching 15,129.06 points, with a trading volume of 32.457 billion [1]. - Over the past month, the index has risen by 9.35%, by 9.86% over the last three months, and by 8.89% year-to-date [1]. Group 2: Index Composition - The index is composed of listed companies in the healthcare sector, reflecting the overall performance of these companies [1]. - The top ten weighted companies in the index include Mindray Medical (9.08%), United Imaging (7.41%), Aier Eye Hospital (7.13%), and others [1]. - The index's holdings are primarily from the Shenzhen Stock Exchange (59.69%) and the Shanghai Stock Exchange (40.31%) [1]. Group 3: Industry Representation - The index exclusively represents the pharmaceutical and healthcare industry, with a 100% allocation to this sector [1]. Group 4: Index Adjustment and Fund Tracking - The index samples are adjusted biannually, with changes implemented on the next trading day following the second Friday of June and December [2]. - Public funds tracking the healthcare index include various Southern and Tianhong funds, as well as ETFs from multiple asset management companies [2].

Core Viewpoint - Next week, 25 stocks will have their restrictions lifted, with a total market value of 79.529 billion yuan based on the latest closing prices [1] Group 1: Stock Unlocking Details - United Imaging Healthcare will have 231 million shares available for trading, primarily consisting of original shareholders' restricted shares, with a market value of 29.541 billion yuan [1] - GeKong Microelectronics follows with 1.05 billion shares set to be unlocked, also mainly from original shareholders' restricted shares, amounting to a market value of 16.391 billion yuan [1] Group 2: Unlocking Ratios - Hualan Biological Engineering has the highest unlocking ratio at 76.37% [1] - Other companies with significant unlocking ratios include Zhongchu Catalyst, GeKong Microelectronics, Luvi Optoelectronics, and Huicheng Co., Ltd. [1]

Core Viewpoint - The announcement from United Imaging Healthcare regarding the initial public offering (IPO) of restricted shares indicates a significant step in the company's market presence and capital raising efforts [1] Summary by Relevant Sections Stock Listing Details - The type of stock listing is for the initial issuance of restricted shares [1] - The method of stock subscription is offline [1] - The total number of shares to be listed is 230,859,012 shares [1] - The total number of shares available for circulation upon listing is also 230,859,012 shares [1] - The listing date for the shares is set for August 22, 2025 [1]

证券代码：688271 证券简称：联影医疗 公告编号：2025-031 上海联影医疗科技股份有限公司 首次公开发行部分限售股上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 本次股票上市类型为 首发限售股份 ；股票认购方式为 网下 ，上市股数为 本次股票上市流通总数为230,859,012股。 ? 本次股票上市流通日期为2025 年 8 月 22 日。 一、本次上市流通的限售股类型 根据中国证券监督管理委员会于 2022 年 6 月 22 日出具的《关于同意上海联 影医疗科技股份有限公司首次公开发行股票注册的批复》（证监许可[2022]1327 号），上海联影医疗科技股份有限公司（以下简称"联影医疗"或"公司"）获准 向社会公开发行人民币普通股（A 股）100,000,000 股，并于 2022 年 8 月 22 日在 上海证券交易所科创板上市交易。首次公开发行后公司总股本为 824,157,988 股， 其中有限售条件流通股为 776,907,446 股，无限售条件流通股为 47,250, ...

2024年1至12月份，联影医疗的营业收入构成为：医疗器械行业占比95.96%，其他业务占比4.04%。 （文章来源：每日经济新闻） 联影医疗（SH 688271，收盘价：127.96元）8月15日晚间发布公告称，公司限售股份约2.31亿股将于 2025年8月22日解禁并上市流通，占公司总股本比例为28.01%。 ...

证券代码：688271 证券简称：联影医疗 公告编号：2025-031 上海联影医疗科技股份有限公司 首次公开发行部分限售股上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次股票上市类型为首发限售股份；股票认购方式为网下，上市股数为 230,859,012股。 本次股票上市流通总数为230,859,012股。 致股本数量变化的情况。 三、本次上市流通的限售股的有关承诺 1、公司实际控制人薛敏就所持公司股份锁定事宜作出承诺如下： （1）自发行人股票在上海证券交易所科创板上市之日起 36 个月内，本人不 转让或委托他人管理本人在本次公开发行前直接或间接持有的发行人股份，也不 由发行人回购该部分股份。 本次股票上市流通日期为2025 年 8 月 22 日。 一、本次上市流通的限售股类型 根据中国证券监督管理委员会于 2022 年 6 月 22 日出具的《关于同意上海联 影医疗科技股份有限公司首次公开发行股票注册的批复》（证监许可[2022]1327 号），上海联影医疗科技股份有限公司（以下简称"联 ...